Overview of the neurotoxic effects in solvent-exposed workers

Archives of Public Health

Volumn 60, Issue 3-4, 2002, Pages 217-232

  Viaene, M K ^a,b  

^a Governmental Psychiatric Hospital   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chronic toxic encephalopathy; Neurotoxicity syndromes; Organic solvents

Indexed keywords

SOLVENT;

ARTICLE; BIOLOGICAL MONITORING; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC BRAIN DISEASE; CHRONIC TOXICITY; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; HUMAN; MEDICAL LITERATURE; NEUROTOXICITY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PERIPHERAL NEUROPATHY; RISK ASSESSMENT; WORKER;

EID: 0036403189     PISSN: 07787367     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Dick RB. Neurobehavioral assessment of occupationally relevant solvents and chemicals in humans. In: Chang LW, Dyer IRS, editors. Handbook of Neurotoxicology. Marcel Dekker, Inc. NY, 1995: 217-32.
2. Pryor GT. Solvent-induced neurotoxicity: effects and mechanisms. In: Chang LW, Dyer RS, editors. Handbook of Neurotoxicology. New York: Marcel Dekker, Inc; 1995: 377-400.
3. White R. Clinical neuropathological investigation of solvent neurotoxicity. In: Chang LW, Dyer RS, editors. Handbook of Neurotoxicology. New York: Marcel Dekker, Inc; 1995: 335-76.
4. Viaene MK. [Review of the literature: Neurotoxicity due to occupational exposure to organic solvents.] Publication of Fund for Occupational Diseases, Sterrenkundelaan 1, 1210 Brussel; 1998.
5. Welch L, Krishner H, Health A, Gilliland R, Broyles S. Chronic neurophysiological and neurological impairment following acute exposure to a solvent mixture of toluene and methyl ethyl ketone (MEK). Clin Toxicol 1991; 29: 435-45.
6. Houck P, Nebel D, Milham S. Organic solvent encephalopathy: an old hazard revisited. Am J Ind Med 1992; 22: 109-15.
7. Seaton A, Jellinek EH, Kennedy P. Major neurological disease and exposure to organic solvents. Q J Med 1992; 84: 707-12.
8. Stollery BT, Flindt MLH, Ffom MB. Memory sequelae of solvent intoxication. Scand J Work Environ Health 1988; 14: 45-8.
9. Carpenter CP, Schaffer CB, Weil CS, Smyth JR. HF. Studies on the inhalation of 1: 3 butadiene with a comparison of its narcotic effect with benzol, toluol and styrene. J Ind Hyg 1944; 26: 69-78.
10. Gamberale F, Hultengren M. Exposure to styrene II. Psychological functions. Work Environm Hlth 1974; 11: 86-93.
11. Bruhn P, Arlien-Søborg P, Gyldensted C, Christensen EL. The prognosis of chronic toxic encephalopathy. A two year follow-up study in 26 house painters with occupational encephalopathy. Acta Neurol Scand 1981; 64: 259-72.
12. Seppäläinen AM, Antti-Poika M. Time course of electrophysiological findings in patients with solvent poisoning: a descriptive study. Scand J Work Environ Health 1983; 9: 15-24.
13. McCord G. Toxicity of methyl alcohol (methanol) following skin absorption and inhalation. Ind Eng Chem 1931; 23: 931-6.
14. Bemsen HJ, Verhagen WI, De Bijl MA, Heerschap A. Magnetic resonance studies on brain dysfunction induced by organic solvents. Acta Neurol Belg 1992; 92: 207-14.
15. Callender TJ, Morrow L, Subramanian K, Duhon D, Ristovv M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res 1993; 60: 295-319.
16. Ellingsen DG, Lorentzen P, Langård S. A neuropsychological study of patients exposed to organic solvents. Int J Occup Environ Health 1997; 3: 177-83.
17. Anger WK. Worksite behavioral research: results, sensitive methods, test batteries and transition from laboratory data to human health. Neurotoxicology 1990; 11 : 627-720.
18. Anger WK. Behavioral markers to identify neurotoxic effects. In Travis CC, editor. Use of biomarkers in assessing health and environmental impacts of chemical pollutants. Plenum Press, NY, 1993: 159-67.
19. Struwe G, Wennberg A. Psychiatric and neurological symptoms in workers occupationally exposed to organic solvents-results of a differential epidemiological study. Acta Psych Scand 1983; 67 (Suppl 303): 68-80.
20. D'Andrea F, Cavassini P, Perbellini L, Apostoli P, Zampieri P. Alterazioni vestibolari in operai calzaturieri. Med Lavoro 1979; 1: 16-20.
21. Bulterys S. Het opvolgen van solvent-blootgestelden in de arbeidsgeneeskundige praktijk. Problemen van Arbeidsgeneeskunde 1995; 30: 212-24.
22. Elofsson SA, Gamberale F, Hindmarsh T, Iregren A, Isaksson A, Johnsson I, Knave B, et al. Exposure to organic solvents. Scand J Environ Health 1980; 7: 239-73.
23. Viaene MK, Pauwels W, Veulemans H, Roels HA, Masschelein R. Neurobehavioural changes and persistence of complaints in workers exposed to styrene in a ployester boat building plant: influence of exposure characteristics and microsomal epoxide hydrolase phenotype. Occup environ Med 2001; 58: 103-12.
24. Juntunen J, Matikainen E, Antti-Poika M, Suoranta H, Valle M. Nervous system effects of long-term occupational exposure to toluene. Acta Neurol Scand 1985; 72: 512-7.
25. Mikkelsen S, Jorgensen M, Browne E, Gyldensted C. Mixed solvent exposure and organic brain damage. A study of painters. Acta Neurol Scand Suppl 1988; 118: 1-143.
26. Sabroe S, Olsen J. The occurrence of disability and early old-age pensions among members of the carpenters and cabinet makers' trade union. Scand J Soc Med Suppl 1980; 16: 28-33.
27. Olsen J, Sabroe S. A case-reference study of neuropsychiatric disorders among workers exposed to solvents in the Danish wood and furniture industry. Scand J Soc Med 1980; 16 (Suppl): 44-9.
28. Cherry NM, Labrèche FP, Mcdonald JC. Organic brain damage and occupational solvent exposure. Br J Ind Med 1992; 49: 776-81.
29. Van Vliet C, Swaen GMH, Volovics A, Slangen JJM, Meijers JMM, De Boorder TJ, et al. Exposure-outcome relationships between organic solvent exposure and neuropsychiatric disorders: results from a Dutch case-control study. Am J Ind Med 1989; 16: 707-18.
30. ACGIH. Threshold limit values for chemical substances physical agents and biological exposure indices. American Conference of Governmental Industrial Hygienists (ACGIH), Technical Affairs Office, Kemper Woods Center, 1330 Kemper Meadow Drive, Cincinnati, 1994-1995.
31. Edling C, Anundi H, Johanson G, Nilsson K. Increase in neuropsychiatric symptoms after occupational exposure to low levels of styrene. Br J Ind Med 1993; 50: 843-50.
32. Bleecker ML, Bolla KI, Agnew J, Schwartz BS, Ford DP. Dose-related subclinical neurobehavioral effects of chronic exposure to low levels of organic solvents. Am J Ind Med 1991; 19: 715-28.
33. Linz DH, De Garmo PL, Morton WE, Wiens AN, Coull BM, Maricle RA. Organic Solvent-induced encephalopathy in industrial painters. J Occup Med 1986; 28: 119-25.
34. Fund for Occupational Diseases. "Erkenningscriteria voor OPS" [Brochure]. FBZ, Sterrenkundelaan 1, 1210 Brussel, 1999.
35. Kanada M, Miyagawa M, Sato M, Hasegawa H, Honma T. Neurochemical profile of effects of 28 neurotoxic chemicals on the central nervous system in rats. (1) effects of oral administration on brain contents of biogenic amines and metabolites. Ind Health 1994; 32: 145-64.
36. Veulemans H, Daems J, Masschelein R. [Polyester ship building. Air monitoring and biomonitoring.] Cahiers Arbeidsgeneesk 1986; 22: 75-83.
37. Daems J, Masschelein R, Veulemans H. [Health care in a fibreglass boat building factory.] Cahiers Arbeidsgeneeskunde 1986; 23: 289-95.
38. Vernaillen I. [Color vision disturbances in solvent exposed printers: a cross-sectional study.] Thesis Arbeidsgeneeskunde. Centrum voor Preventieve Gezondheidszorg. K.U. Leuven, 1997.
39. Lundberg I, Högberg M, Michélsen H, Nise G, Hogstedt C. An evaluation of the questionnaire Q16 (Q16) on neurotoxic symptoms. Book of Abstracts Part II, 25th International Congress on Occupational Health, Stockholm 1996: 213.
40. Hooisma J, Emmen HH. [Defining the normal data of the Neurotoxicity Symptom Checklist-60 (NSC-60).] Publicatie Stichting Arbouw, Amsterdam 1992.
41. Bulterys S, Viaene MK. The development of a screening test for the neuropsychological evaluation of solvent-exposed workers. 5th International Symposium on Neurobehavioral Methods and Effects in Occupational and Environmental Health; 1994 Dec 3-7; Cairo, Egypt.
42. Michiels K. [Neurotoxicity due to solvent exposure ten gevolge van solventblootstelling.] Thesis Arbeidsgeneeskunde. Centrum voor Preventieve Gezondheidszorg. K.U. Leuven, 2000.
43. Mikkelsen S. Solvent encephalopathy: disability pension studies and other case-studies. In: Chang LW, Dyer RS, editors. Handbook of neurotoxicology. New York: Marcel Dekker, Inc; 1995: 323-38.
44. WHO publications. Organic solvents and the central nervous system. Environ Health 5. Copenhagen 1985: 1-39.
45. Campagna D, Mergler D, Picot A, Sahuquillo J, Belanger S, Pleven C, Brun A, Leclerc-Marzin MP, Lamotte G, Huel G. [Monitoring neurotoxic effects among laboratory personnel working with organic solvents.] Rev Epidemiol Sante Publique 1995; 43: 519-32.
46. Van Den Hoofdakker RH, Albersnagel FA, De Cuyper H. Stemming-stoomissen. In: Vandereycken W, Hoogduin CAL, Emmelkamp PMG, editors. Handboek psychopathologie. Deel 1. Basisbegrippen. 1994. p. 164-203.
47. Rasmussen H, Olsen J, Lauritsen J. Risk of encephalopathia among retired solvent-exposed workers. J Occup Med 1985; 27: 561-6.
48. Vigliani EC. Carbon disulphide poisoning in viscose rayon factories. Br J Ind Med 1954; 11: 235-44.
49. Knave B, Anshelm Olsen B, Elofsson S, Gamberale F, Isaksson A, et al. Long-term exposure to jet fuel. II A cross-sectional epidemiological investigation on occupationally exposed industrial workers with special reference to the nervous system. Scand J Work Environ Health 1978; 4: 19-45.
50. Devriese S, Winters W, Stegen K, Van Diest I, Veulemans H, Nemery B, Eelen P, Van De Woestijne K, Van Den Bergh O. Generalization of acquired somatic symptoms in response to odors: a pavlovian perspective on multiple chemical sensitivity. Psychosom Med 2000; 62: 751-9.
51. Morrow LA, Ryan CM, Hodgson MJ, Robin N. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J Nerv Ment Dis 1991; 179: 540-5.
52. Creasey H, Jorm A, Longley W, Broe GA, Henderson AS. Monozygotic twins discordant for Alzheimer's disease. Neurology 1989; 39: 1474-6.
53. Calne DB. Is idiopathic Parkinsonism the consequence of an event or a process? Neurology 1994; 44: 5-10.
54. Tanner CM. Occupational and environmental causes of Parkinsonism. Occup Med 1992(a); 7: 503-13.
55. Tanner CM. Epidemiology of Parkinson's disease. Neurol Clin 1992(b); 10: 317-29.
56. Mulloy KB. Two case reports of neurological disease in coal mine preparation plant workers. Am J Ind Health 1996; 30: 56-61.
57. Barbosa ER, Comerlatti LR, Haddad MS, Scaff M. Parkinsonism secondary to ethylene oxide exposure: [case report.] Arq Neuropsiquiatr 1992; 50: 531-530.
58. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents. J Occup Med 1994; 36: 1079-92.
59. DSM-IV. Beknopte handleiding bij de diagnostische criteria van de DSM-IV. American Psychatric Association. Publ. Swets&Zeitlinger BV. 1995.
60. Axelson O, Hane M, Hogstedt C. A case-referent study on neuropsychiatric disorders among workers exposed to solvents. Scand J Work Environ Health 1976; 2: 14-20.
61. Mikkelsen S. A cohort study of disability pension and death among painters with special regard to disabling presenile dementia as an occupational disease. Scand J Soc Med Suppl 1980; 16: 34-43.
62. Viaene MK Acute en chronische neurotoxische effecten van styreen en hun reversibiliteit. Resultaten van een cross-sectioneel onderzoek bij werknemers tewerkgesteld in de glasvezelversterkte polyesterinclustrie. [PhD thesis]. Department of Occupational Health, Catholic University of Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium. 1998(b).
63. Laire G, Viaene MK, Veulemans H, Masschelein R, Nemery B. Nocturnal desaturations, as assessed by home-oxymetry, in long-term solvent exposed workers. Am J Ind Health 1997; 32: 656-64.
64. De Haro L, Jouglard J, Jahjah F, Sainty JM, Chave B, Qura B. Psychosyndrome aux solvants et recherche du syndrome d'apnées du sommeil. Arch Mal Prof 1995; 2: 145-7.
65. Monstad P, Mellgren S, Sulg I. The clinical significance of sleep apnoea in workers exposed to organic solvents: implications for the diagnosis of organic solvent encephalopathy. J Neurol 1992; 239: 195-8.
66. Seppäläinen AM. Neurophysiological aspects of the toxicity of organic solvents. Scand J Work Environ Health 1985; 11 (Suppl 1): 61-4.
67. Martindale. The extra pharmacopoeia. 30th edition. The Pharmaceutical Press, 1993: 918-9.
68. Landtblom AM. Exposure to organic solvents and multiple sclerosis. Neurology 1997; 49 (suppl 2): 70-4.
69. Vanhoorne M. Epidemiological and medico-social study of the toxic effects of occupational exposure to carbon disulphide. PhD thesis, Department of Hygiene and Social Medicine. University of Ghent. 1992.
70. Baker EL. Neurologic disorders. In: Rom WN, editor. Environmental and occupational Medicine. Boston: Little Brown & Co, 1992: 561-72.
71. Schaumburg HH, Spencer PS. Toxic neuropathies. Neurology 1979; 29: 429-31.
72. Bos PM, De Mik G, Bragt PC. Critical review of the toxicity of methyl n-butyl ketone: risk from occupational exposure. Am J Ind Med 1991; 20: 175-94.
73. Zampollo A, Zachetti O, Pisati G. On ethylene oxide neurotoxicity: report of two cases of peripheral polyneuropathy. Ital J Neurol Sci 1984; 5: 59-62.
74. Feldman RG, Mayer MM, Taub A. Evidence for peripheral neurotoxic effect of trichloroethylene. Neurol 1970; 20: 599-606.
75. Feldman RG, Niles C, Proctor SP, Jabre J. Blink reflex measurement of effects of trichloroethylene exposure on the trigeminal nerve. Muscle Nerve 1992; 15: 490-5.
76. Ruijten MW, Verberk MM, Salle HJ. Nerve function in workers with long term exposure to trichloroethene. Br J Ind Med 1991; 48: 87-92.
77. Rasmussen K, Jeppesen HJ, Sabroe S. Solvent-induced chronic toxic encephalopathy. Am J Ind Med 1993; 23: 779-92.
78. Freeman RW, Bleecker ML, Comstock GW, Brookmeyer RS. Validation of self-administered questionnaire for study of peripheral neuropathy. Am J Epidemiol 1985; 121: 291-300.
79. Mergler D, Blain L, Lagacé JP. Solvent related colour vision loss: an indicator of neuronal damage? Int Arch Occup Environ Health 1987; 59: 313-21.
80. Schwartz BS, Ford P, Bolla KI, Agnew J, Bleecker M. Solvent-associated olfactory dysfunction: not a predictor of deficits in learning and memory. Am J Psychiatry 1991; 148: 751-6.
81. Cavalleri A, Gobba F, Paltrinieri M, Fantuzzi G, Righi E, Aggazzotti G. Perchloroethylene exposure can induce colour vision loss. Neuroscience Letters 1994; 179: 162-6.
82. Bælum J. Human Solvent Exposure. Factors influencing the pharmacokinetics and acute toxicity. Pharmacol Toxicol 1991; 68(suppl 1): 1-36.
83. Raitta C, Teir H, Tolonen M, Nurminen M, Helpiö E, Malström S. Impaired color vision discrimination among viscose rayon workers exposed to carbon disulphide. J Occup Med 1981; 23: 189-92.
84. Gobba FM, Cavalleri A. Styrene exposure and color vision loss. Abstract Book of the International Symposium on Health Hazards of Butadiene and Styrene. Finnish Institute of Occupational Health, Helsinki, 1993: 45.
85. Nakatsuka H, Watanabe T, Takeuchi Y, Hisanaga N, Shibata E, Suzuki H, et al. Absence of blue-yellow color vision loss among workers exposed to toluene or tetrechloroethylene, mostly at levels below occupational exposure limits. Int Arch Occup Environ Health 1992; 64: 113-7.
86. Ruijten MWMM, Sallé HJA, Verberk MM, Muijser H. Special nerve functions and colour discrimination in workers with long term low level exposure exposure to carbon disulphide. Br J Ind Med 1990; 47: 589-595.
87. Rybak LP. Hearing: the effect of chemicals. Otolaryngol Head Neck Surg 1992; 106: 677-86.
88. Pryor GT. Assessment of auditory dysfunction. In: Chang LW, editor. Principles of neurotoxicology. New York: Marcel Dekker, Inc; 1994: 345-73.